Lobbying return by Multiple Sclerosis Ireland
HealthTo secure additional annual statutory funding of €600,000 to open our care centre 50 weeks per year.
Politician · Senator · 27th Seanad
Returns filed on the Register of Lobbying, newest first, with the policy area and intended results as the lobbyist published them.
To secure additional annual statutory funding of €600,000 to open our care centre 50 weeks per year.
To make our elected representatives aware that access to medications is an issue for people living with multiple sclerosis.
Inform public officials about labour force issues in home care(health care assistants)::Discuss and inform public officials about the issues private home care providers face in Ireland::Include Health Care Assistants on the Critical Skills list::Change social welfare rules to…
To ensure members of the Oireachtas Health Committee made aware of the report
Published name "Irish Pharmaceutical Healthcare Association" equals CRO name "IRISH PHARMACEUTICAL HEALTHCARE ASSOCIATION" (CRO 254776) after normalising legal forms such as Ltd = Limited. No other CRO company has this name. Names can be shared, so compare the address and dates on the CRO record.
Full delivery of the National Cancer Strategy
Published name "Irish Cancer Society" equals CRO name "IRISH CANCER SOCIETY" (CRO 20868) after normalising legal forms such as Ltd = Limited. No other CRO company has this name. Names can be shared, so compare the address and dates on the CRO record.
To invite local councillors from Dublin's north inner city, Oireacthas joint committee on health, as well as well as TDs from Dublin Central to the Irish Cancer Society's lung cancer action plan launch
Published name "Irish Cancer Society" equals CRO name "IRISH CANCER SOCIETY" (CRO 20868) after normalising legal forms such as Ltd = Limited. No other CRO company has this name. Names can be shared, so compare the address and dates on the CRO record.
Irish Support for resolution on ‘Improving the transparency of markets for drugs, vaccines, and other health-related technologies’ at the World Health Assembly
Expedite the development of a National Policy Framework on Biosimilars
To build an awareness among TD's and Senators about the work being undertaken by the community activation element of the Dementia: Understand Together campaign
Published name "The Alzheimer Society of Ireland" equals CRO name "THE ALZHEIMER SOCIETY OF IRELAND" (CRO 102700) after normalising legal forms such as Ltd = Limited. No other CRO company has this name. Names can be shared, so compare the address and dates on the CRO record.
To secure additional annual statutory funding of €600,000 to open our care centre 50 weeks per year.
To make our elected representatives aware that access to medications is an issue for people living with multiple sclerosis.
Meeting; Participation on panel
Seeking reform to the reimbursement process and pathway for high tech oncology medicines::Providing update to designated public officials on AstraZeneca medicines currently undergoing the reimbursement process
Published name "Hanover Media Strategy Limited" equals CRO name "HANOVER MEDIA STRATEGY LIMITED" (CRO 596029) after normalising legal forms such as Ltd = Limited. No other CRO company has this name. Names can be shared, so compare the address and dates on the CRO record.
Awareness of the need to invest in and implement specific policy and service frameworks and initiatives in order to improve access to services for Irish people with neurological conditions::Call for investment to support the implementation of the National Policy and Strategy for…
Published name "Neurological Alliance of Ireland" has no legal form. "NEUROLOGICAL ALLIANCE OF IRELAND COMPANY LIMITED BY GUARANTEE" (CRO 366603) is the only CRO company with that name plus any legal form (Limited, DAC, UC, CLG, PLC or Teoranta). Confirm against the CRO record before relying on it.
To highlight the objection of the IPU to the proposed PSI (Temporary Absence of Pharmacist from Pharmacy) Rules and to seek a more equitable and reasonable way to determine the suitability of a pharmaceutical assistant to act in the temporary absence of a pharmacist.